Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul 6;9(7):e04454.
doi: 10.1002/ccr3.4454. eCollection 2021 Jul.

Fatal cerebral venous sinus thrombosis as a manifestation of uncontrolled systemic lupus erythematosus in a young African female

Affiliations
Case Reports

Fatal cerebral venous sinus thrombosis as a manifestation of uncontrolled systemic lupus erythematosus in a young African female

Abid M Sadiq et al. Clin Case Rep. .

Abstract

In a young patient with systemic lupus erythematosus presenting with status epilepticus and neurological deficits, early brain imaging, risk factor identification and prompt treatment of underlying lupus flare-up and cerebral venous sinus thrombosis could significantly improve the management and prognosis.

Keywords: brain infarction; intracranial hemorrhage; sub‐Saharan Africa; systemic lupus erythematosus; venous sinus thrombosis.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
MRI axial flair (A and B) and axial T2 gradient echo (C and D) showing hemorrhagic infarction (blue arrow) in the right parietal lobe (A and C) and left fronto‐basal lobe (B and D) with surrounding vasogenic edema
FIGURE 2
FIGURE 2
MRV showing a filling defect (blue arrow) in the superior sagittal sinus (A) and right transverse sinus (B) in keeping with right parietal and left fronto‐basal lobe venous hemorrhagic infarction secondary to venous sinus thrombosis

References

    1. Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011;40(1):42‐49. 10.1007/s12016-009-8192-4 - DOI - PMC - PubMed
    1. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica. 2011;6(4):330‐336. http://www.ncbi.nlm.nih.gov/pubmed/22879850 - PMC - PubMed
    1. Mosca M, Merrill J, Bombardieri S. Assessment of disease activity in systemic lupus erythematosus. In: Systemic Lupus Erythematosus, 1st edn. Philadelphia: Mosby; 2007:19‐23.
    1. Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017;28(1):4‐12. 10.31138/mjr.28.1.4 - DOI - PMC - PubMed
    1. Zhang Y, Han H, Chu L. Neuropsychiatric lupus erythematosus: future directions and challenges; a systematic review and survey. Clinics. 2020;75(4):1‐7. 10.6061/clinics/2020/e1515 - DOI - PMC - PubMed

Publication types

LinkOut - more resources